New developments in the assessment of COPD: early diagnosis is key

References

• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
   PubMed Web of Science ®Google Scholar
• DecramerMCooperCBTreatment of COPD: the sooner the better?Thorax201065983784120805184
   PubMed Web of Science ®Google Scholar
• DecramerMMiravitllesMPriceDNew horizons in early stage COPD – improving knowledge, detection and treatmentRespir Med2011105111576158721239156
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J19771607716451648871704
   PubMed Web of Science ®Google Scholar
• TantucciCModinaDLung function decline in COPDInt J Chron Obstruct Pulmon Dis20127959922371650
   PubMed Web of Science ®Google Scholar
• DrummondMBHanselNNConnettJEScanlonPDTashkinDPWiseRASpirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185121301130622561963
   PubMed Web of Science ®Google Scholar
• BorrillZLHoughtonCMTal-SingerRThe use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPDBr J Clin Pharmacol200865224425218251761
   PubMed Web of Science ®Google Scholar
• BorrillZLHoughtonCMWoodcockAAVestboJSinghDMeasuring bronchodilation in COPD clinical trialsBr J Clin Pharmacol200559437938415801931
   PubMed Web of Science ®Google Scholar
• FrantzSNihlénUDenckerMEngströmGLöfdahlCGWollmerPImpulse oscillometry may be of value in detecting early manifestations of COPDRespir Med201210681116112322613172
   PubMed Web of Science ®Google Scholar
• OppenheimerBWGoldringRMBergerKIDistal airway function assessed by oscillometry at varying respiratory rate: comparison with dynamic complianceCOPD20096316217019811371
   PubMedGoogle Scholar
• MetsOMSchmidtMBuckensCFDiagnosis of chronic obstructive pulmonary disease in lung cancer screening computed tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickeningRespir Res2013145923711184
   PubMed Web of Science ®Google Scholar
• OwrangiAMEtemad-RezaiRMcCormackDGCunninghamIAParragaGComputed tomography density histogram analysis to evaluate pulmonary emphysema in ex-smokersAcad Radiol201320553754523570935
   PubMed Web of Science ®Google Scholar
• JohannessenASkorgeTDBottaiMMortality by level of emphysema and airway wall thicknessAm J Respir Crit Care Med2013187660260823328525
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialLancet200937496961171117819716598
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• CukicVLovreVUstamujicAThe Changes of Pulmonary Function in COPD During Four-Year PeriodMater Sociomed2013252889224082829
   PubMedGoogle Scholar
• CorsiDJBoyleMHLearSAChowCKTeoKKSubramanianSVTrends in smoking in Canada from 1950 to 2011: progression of the tobacco epidemic according to socioeconomic status and geographyCancer Causes Control2014251455724158778
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionCigarette smoking among adults – United States, 2007MMWR Morb Mortal Wkly Rep200857451221122619008790
   PubMedGoogle Scholar
• SongYZhaoLPalipudiKMGlobal Adult Tobacco Survey (GATS) Collaborative GroupTracking MPOWER in 14 countries: results from the Global Adult Tobacco Survey, 2008–2010Glob Health Promot Epub9162013
   Google Scholar
• AccordiniSCorsicoAGCerveriIDiverging trends of chronic bronchitis and smoking habits between 1998 and 2010Respir Res2013141623394461
   PubMed Web of Science ®Google Scholar
• NelsonDEMoweryPAsmanKLong-term trends in adolescent and young adult smoking in the United States: metapatterns and implicationsAm J Public Health200898590591518382001
   PubMed Web of Science ®Google Scholar
• FordESCroftJBManninoDMWheatonAGZhangXGilesWHCOPD surveillance – United States, 1999–2011Chest2013144128430523619732
   PubMed Web of Science ®Google Scholar
• FordESManninoDMWheatonAGGilesWHPresley-CantrellLCroftJBTrends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988–1994 to 2007–2010Chest201314351395140623715520
   PubMed Web of Science ®Google Scholar
• ManninoDMHomaDMAkinbamiLJFordESReddSCChronic obstructive pulmonary disease surveillance – United States, 1971–2000MMWR Surveill Summ2002516116
   Google Scholar
• ShahabLJarvisMJBrittonJWestRPrevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sampleThorax200661121043104717040932
   PubMed Web of Science ®Google Scholar
• ZhongNWangCYaoWPrevalence of chronic obstructive pulmonary disease in China: a large, population-based surveyAm J Respir Crit Care Med2007176875376017575095
   PubMed Web of Science ®Google Scholar
• YinPZhangMLiYJiangYZhaoWPrevalence of COPD and its association with socioeconomic status in China: findings from China Chronic Disease Risk Factor Surveillance 2007BMC Public Health20111158621781320
   PubMed Web of Science ®Google Scholar
• LouPZhuYChenPVulnerability of patients with chronic obstructive pulmonary disease according to gender in ChinaInt J Chron Obstruct Pulmon Dis2012782583223277738
   PubMed Web of Science ®Google Scholar
• ZengGSunBZhongNNon-smoking-related chronic obstructive pulmonary disease: a neglected entity?Respirology201217690891222845669
   PubMed Web of Science ®Google Scholar
• HuGZhouYTianJRisk of COPD from exposure to biomass smoke: a metaanalysisChest20101381203120139228
   PubMed Web of Science ®Google Scholar
• SoodAPetersenHBlanchetteCMWood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokersAm J Respir Crit Care Med201018291098110420595226
   PubMed Web of Science ®Google Scholar
• NishimuraMMakitaHNagaiKHokkaido COPD Cohort Study InvestigatorsAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
   PubMed Web of Science ®Google Scholar
• TanabeNMuroSTanakaSEmphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary diseaseRespir Res2012133122512922
   PubMed Web of Science ®Google Scholar
• Mohamed HoeseinFAvan RikxoortEvan GinnekenBComputed tomography-quantified emphysema distribution is associated with lung function declineEur Respir J201240484485022323577
   PubMed Web of Science ®Google Scholar
• AgustiACalverleyPMCelliBEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohortRespir Res20101112220831787
   PubMed Web of Science ®Google Scholar
• CouperDLavangeLMHanMSPIROMICS Research GroupDesign of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)Thorax Epub9122013
   Web of Science ®Google Scholar
• ReganEAHokansonJEMurphyJRGenetic epidemiology of COPD (COPDGene) study designCOPD201071324320214461
   PubMedGoogle Scholar
• RennardSIVestboJAgustíAWhat is chronic obstructive pulmonary disease anyway?: Continua, categories, cut points, and moving beyond spirometryAm J Respir Crit Care Med2013187101036103723675708
   PubMed Web of Science ®Google Scholar
• EnrightPLRuppelGLDon’t use the flawed fixed ratio to diagnosis COPDRespir Care20095411150019863837
   PubMed Web of Science ®Google Scholar
• Mohamed HoeseinFAZanenPLammersJWLower limit of normal or FEV1/FVC <0.70 in diagnosing COPD: an evidence-based reviewRespir Med2011105690791521295958
   PubMed Web of Science ®Google Scholar
• BhattSPSierenJCDransfieldMTCOPDGene InvestigatorsComparison of spirometric thresholds in diagnosing smoking-related airflow obstructionThorax Epub1152013
   Google Scholar
• JögiJEkbergMJonsonBBozovicGBajcMVentilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCTEur J Nucl Med Mol Imaging20113871344135221365251
   PubMed Web of Science ®Google Scholar
• National Cancer InstituteBiomarkerNCI Dictionary of Terms [website on the Internet]Bethesda, MDNational Cancer Institute nd. Available from: http://www.cancer.gov/dictionary?cdrid=45618Accessed December 1, 2013
   Google Scholar
• CarolanBJKimYIWilliamsAAThe association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013188556156623777323
   PubMed Web of Science ®Google Scholar
• ChengDTKimDKCockayneDATESRA and ECLIPSE InvestigatorsSystemic soluble receptor for advanced glycation end-products is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013188894895723947473
   PubMed Web of Science ®Google Scholar
• WangLTangYLiuSMetabonomic profiling of serum and urine by (1)H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individualsPLoS One201386e6567523755267
   PubMed Web of Science ®Google Scholar
• ThomashowMAShimboDParikhMAEndothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease studyAm J Respir Crit Care Med20131881606823600492
   PubMed Web of Science ®Google Scholar
• KharitonovSABarnesPJExhaled markers of pulmonary diseaseAm J Respir Crit Care Med200116371693172211401895
   PubMed Web of Science ®Google Scholar
• BarnesPJChowdhuryBKharitonovSAPulmonary biomarkers in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174161416556692
   PubMed Web of Science ®Google Scholar
• BrindicciCItoKRestaOPrideNBBarnesPJKharitonovSAExhaled nitric oxide from lung periphery is increased in COPDEur Respir J2005261525915994389
   PubMed Web of Science ®Google Scholar
• BorrillZLRoyKSinghDExhaled breath condensate biomarkers in COPDEur Respir J200832247248618669788
   PubMed Web of Science ®Google Scholar
• PelkonenMTukiainenHTervahautaMPulmonary function, smoking cessation and 30 year mortality in middle aged Finnish menThorax200055974675010950892
   PubMed Web of Science ®Google Scholar
• ChapmanRSHeXBlairAELanQImprovement in household stoves and risk of chronic obstructive pulmonary disease in Xuanwei, China: retrospective cohort studyBMJ20053317524105016234255
   PubMed Web of Science ®Google Scholar
• EdwardsRDLiuYHeGHousehold CO and PM measured as part of a review of China’s National Improved Stove ProgramIndoor Air200717318920317542832
   PubMed Web of Science ®Google Scholar
• FreemanDLeeAPriceDEfficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) studyRespir Res200784517605774
   PubMed Web of Science ®Google Scholar
• DusserDBravoMLIaconoPThe effect of tiotropium on exacerbations and airflow in patients with COPDEur Respir J200627354755516507855
   PubMed Web of Science ®Google Scholar
• Boehringer Ingelheim PharmaceuticalsEffects of tiotropium on breathing capacity and exercise limitation in early stages of chronic obstructive pulmonary diseaseClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2010 [updated November 27, 2013]. Available from: http://clinicaltrial.gov/ct2/show/study/NCT1072396. NLM identifier: NCT1072396Accessed December 2, 2013
   Google Scholar
• TseHNRaiteriLWongKYHigh-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE studyChest2013144110611823348146
   PubMed Web of Science ®Google Scholar
• BarnesPJTheophyllineAm J Respir Crit Care Med2013188890190623672674
   PubMed Web of Science ®Google Scholar
• Hospital Universitari Son DuretaEffects of low-dose theophylline during chronic obstructive pulmonary disease (COPD) exacerbationsClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2008 [updated May 2, 2008]. Available from: http://clinicaltrial.gov/ct2/show/NCT0671151. NLM identifier: NCT0671151Accessed December 2, 2013
   Google Scholar
• Hospital Son EspasesLow-dose theophylline as anti-inflammatory enhancer in severe chronic obstructive pulmonary disease (ASSET)ClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2012 [updated May 15, 2012]. Available from: http://clinicaltrial.gov/ct2/show/NCT1599871. NLM identifier: NCT1599871Accessed December 2, 2013
   Google Scholar
• Assaf-Harofeh Medical CenterThe effect on small airways of addition of theophylline as inducer of histone deacilase activity for patients with moderate to severe chronic obstructive pulmonary disease (COPD), treated with inhaled steroids and long acting beta agonistsClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2009 [updated April 4, 2011]. Available from: http://clinicaltrial.gov/ct2/show/NCT0893009. NLM identifier: NCT0893009Accessed December 2, 2013
   Google Scholar
• BarnesPJNew anti-inflammatory targets for chronic obstructive pulmonary diseaseNat Rev Drug Discov201312754355923977698
   PubMed Web of Science ®Google Scholar
• WeissDJCasaburiRFlanneryRLeRoux-WilliamsMTashkinDPA placebo-controlled, randomized trial of mesenchymal stem cells in COPDChest201314361590159823172272
   PubMed Web of Science ®Google Scholar
• LacasseYGoldsteinRLassersonTJMartinSPulmonary rehabilitation for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20064CD00379317054186
   PubMed Web of Science ®Google Scholar
• NiciLDonnerCWoutersEATS/ERS Pulmonary Rehabilitation Writing CommitteeAmerican Thoracic Society/European Respiratory Society statement on pulmonary rehabilitationAm J Respir Crit Care Med2006173121390141316760357
   PubMed Web of Science ®Google Scholar
• PuhanMAGimeno-SantosEScharplatzMTroostersTWaltersEHSteurerJPulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseCochrane Database Syst Rev201110CD00530521975749
   PubMed Web of Science ®Google Scholar
• LiuXLTanJYWangTEffectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trialsRehabil Nurs2014391365923780865
   PubMed Web of Science ®Google Scholar
• Van RemoortelHHornikxMDemeyerHDaily physical activity in subjects with newly diagnosed COPDThorax2013681096296323604460
   PubMed Web of Science ®Google Scholar
• JácomeCIMarquesASPulmonary rehabilitation for mild chronic obstructive pulmonary disease: a 1 systematic reviewRespir Care Epub1082013
   Google Scholar
• National Lung Screening Trial Research TeamAberleDRAdamsAMReduced lung-cancer mortality with low-dose computed tomographic screeningN Engl J Med2011365539540921714641
   PubMed Web of Science ®Google Scholar
• DirvenJATangeHJMurisJWvan HaarenKMVinkGvan SchayckOCEarly detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environmentsPrim Care Respir J201322333133723966214
   PubMedGoogle Scholar
• DirvenJATangeHJMurisJWvan HaarenKMVinkGvan SchayckOCEarly detection of COPD in general practice: implementation, workload and socioeconomic status. A mixed methods observational studyPrim Care Respir J201322333834323966213
   PubMedGoogle Scholar
• CastilloDGuaytaRGinerJFARMAEPOC groupCOPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot studyRespir Med2009103683984519200706
   PubMed Web of Science ®Google Scholar
• Collegide Farmacèutics de la Província de BarcelonaChronic obstructive pulmonary disease case finding in community-pharmacies by spirometry (FARMAEPOC)ClinicalTrials.gov [website on the Internet]Bethseda, MDUS National Library of Medicine2012 [updated April 11, 2012]. Available from: http://clinicaltrial.gov/ct2/show/NCT1576068. NLM identifier: NCT1576068Accessed December 2, 2013
   Google Scholar
• PriceDFreemanDClelandJKaplanACerasoliFEarlier diagnosis and earlier treatment of COPD in primary carePrim Care Respir J2011201152220871945
   PubMedGoogle Scholar